Boxes down, efficiency up; JPT has a new home! 📦🚀 Curious where JPT Peptide Technologies is settling in? Our new headquarters marks a bold step forward for growth, innovation, and excellence in the peptide industry. Despite unexpected hurdles (including the longest power outage since World War II in Berlin 🙃), we’re proud to share that the move is complete. Here’s what’s new: 🔬 8,000 m² / 92,000 ft² of state-of-the-art facilities ⚙️ Expanded production capacities and automation 🛡️ Improved working and safety conditions 🌱 Enhanced energy efficiency 📍 Our new address (as of September 15, 2025): JPT Peptide Technologies GmbH Hermann-Dorner-Allee 23 12489 Berlin, Germany This isn’t just a new address, it’s a new chapter. We can’t wait to continue pushing boundaries and delivering excellence for our partners worldwide. We’re excited to start this new chapter! share your congratulations, drop a comment, or give us a 👏 to celebrate this milestone with us! #Innovation #LifeSciences #Peptides #Biotech #Growth
JPT Peptide Technologies
Biotechnology Research
Berlin, BE 2,756 followers
We Make Peptides
About us
We are the Peptide Experts! JPT has a large peptide synthesis capacity, providing over 1 million peptides per year. We offer all possible peptide modifications such as macrocyclic peptides, phosphorylated peptides, labeled and tagged peptides, radioligands, isotope labeling and more. Made in Germany Global Support More than 20 Years of Expertise Ethical, Environmental & Health Standards Portfolio: Custom Peptides Our patented technologies in peptide libraries, pools, microarrays, and micro-scale synthesis set us apart as a leader in the field. From micro to large-scale synthesis, our state-of-the-art labs in Germany deliver peptides tailored to your needs. Modified Peptides We produce modified peptides such as long and stapled peptides, dyes, labeled and biotinylated peptides, PTMs, unique building blocks, conjugations, macrocyclic peptides and more. PepMix Peptide Pools Peptide pools for antigen-specific T-cell stimulation in immune monitoring, assay control, cell therapy development, T-cell expansion etc. In addition to custom PepMix peptide pools we have more than 500 PepMixes in stock, for example: Control Pools: CEFX, CEF, Actin, CMV pp65 … Viral Proteins of EBV, SARS-CoV-2, CMV, VZV, HPV … TAA: Prame, NY-ESO-1, MART-1, MAGE A … Clinical Peptides & Pools Our resulting Clinical Grade Peptides have been approved for a variety of clinical applications including immunotherapy and vaccine development, immune monitoring, and clinical proteomics. Please visit our website for more information! JPT Peptide Technologies GmbH Management: Aurélien Claeyssen & Dr. Sierk Poetting Hermann-Dorner-Alle 23, D-12489 Berlin T: +49 30 322980-7878 peptide@jpt.com https://www.jpt.com/ Registration Court: Berlin / Amtsgericht Charlottenburg, HRB 92692 VAT identification number: DE 814044483 Imprint: https://www.jpt.com/support-contact/corporate/imprint/ Privacy Policy: https://www.jpt.com/support-contact/corporate/privacy-policy/
- Website
-
https://www.jpt.com/
External link for JPT Peptide Technologies
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Berlin, BE
- Type
- Privately Held
- Founded
- 2004
- Specialties
- Peptide Synthesis, Peptide Microarrays, Peptide Libraries, Peptide Pools, Proteotypic Peptides, Stable Isotope labeled peptides, Immunotherapy, Clinical Peptides, Peptide Analyses, Custom Peptides, Macrocyclic Peptides, Made in Germany, DOTA peptides, Radioligands, Cell penetrating peptides, T cell controls, and ELISpot Service
Locations
-
Primary
Hermann-Dorner Allee 23
Berlin, BE 12489, DE
Employees at JPT Peptide Technologies
Updates
-
Yes, we were moving. No, the research didn’t stop! 🚛🔬 𝗔 𝗾𝘂𝗶𝗰𝗸 𝘀𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 𝗼𝗻 𝗳𝗿𝗲𝘀𝗵 𝗔𝘂𝗴𝘂𝘀𝘁 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 across drug delivery and vaccine developement, immunotherapy, and more... Over the past month, while we were busy coordinating moving trucks, unpacking endless boxes, and turning our new space into a home, the scientific community was publishing some truly exciting work powered by our peptides. We’re thrilled to share a few of them here: 📜 𝗖𝗼𝗺𝗽𝗮𝗰𝘁 𝗽𝗼𝗹𝘆𝗲𝘁𝗵𝘆𝗹𝗲𝗻𝗶𝗺𝗶𝗻𝗲-𝗰𝗼𝗺𝗽𝗹𝗲𝘅𝗲𝗱 𝗺𝗥𝗡𝗔 𝘃𝗮𝗰𝗰𝗶𝗻𝗲𝘀 ✍ Jorge Moreno Herrero, et al. Nature Nanotechnology (2025): 1-9. This study introduces compact polyethylenimine (PEI)–complexed self-amplifying RNA vaccines that form ~30 nm nanoparticles with improved stability and biofluid compatibility. 📜 𝗧𝗮𝗿𝗴𝗲𝘁𝗶𝗻𝗴 𝗺𝘂𝘁𝗮𝘁𝗲𝗱 𝗞𝗥𝗔𝗦 𝗯𝘆 𝗛𝗟𝗔-𝗔*𝟬𝟮:𝟬𝟭 𝗿𝗲𝘀𝘁𝗿𝗶𝗰𝘁𝗲𝗱 𝗮𝗻𝘁𝗶-𝗞𝗥𝗔𝗦 𝗧𝗖𝗥-𝗺𝗶𝗺𝗶𝗰 𝗖𝗔𝗥 𝗮𝗻𝗱 𝗯𝗶𝘀𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗧 𝗰𝗲𝗹𝗹 𝗲𝗻𝗴𝗮𝗴𝗲𝗿 ✍ Saber Ebrahimi, et al. Journal of Molecular Medicine (2025): 1-16. The study developed TCR-mimic CARs and bispecific T-cell engagers targeting the KRAS^G12V neoantigen in HLA-A*02:01. They showed strong activity against peptide-pulsed cells but limited effects on tumor cells naturally presenting the antigen. 📜 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗮𝗻𝗱 𝘃𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀 𝗳𝗼𝗿 𝗣𝗮𝗿𝗸𝗶𝗻𝘀𝗼𝗻’𝘀 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗳𝗿𝗼𝗺 𝗵𝘂𝗺𝗮𝗻 𝗰𝗲𝗿𝗲𝗯𝗿𝗼𝘀𝗽𝗶𝗻𝗮𝗹 𝗳𝗹𝘂𝗶𝗱 𝘂𝘀𝗶𝗻𝗴 𝗺𝗮𝘀𝘀 𝘀𝗽𝗲𝗰𝘁𝗿𝗼𝗺𝗲𝘁𝗿𝘆-𝗯𝗮𝘀𝗲𝗱 𝗽𝗿𝗼𝘁𝗲𝗼𝗺𝗶𝗰𝘀 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 ✍ Sungtaek Oh, et al. EBioMedicine 118 (2025) by The Lancet Group. The researchers analyzed cerebrospinal fluid proteins to identify biomarkers, and they found protein changes that may help in diagnosing Parkinson’s disease. 📢 If you would like to see the full list of articles, please let us know in the comments or send us a message. #publication #newpublication #immunotherapy #biotechnology
-
-
𝘋𝘳𝘶𝘮𝘳𝘰𝘭𝘭 𝘱𝘭𝘦𝘢𝘴𝘦... 🥁 🥁 🔊 Our peptide of the month is... ⭐ 𝗦𝗲𝗺𝗮𝗴𝗹𝘂𝘁𝗶𝗱𝗲 𝗣𝗲𝗽𝘁𝗶𝗱𝗲 ✨ Besides serving hollywood glamour on the red carpet this molecule is having its moment in diabetes type-2 and obesity research. Working as a GLP-1 receptor agonist, semaluglutide stimulates the release of insulin, reduces glucagon secretion, and slows down gastric emptying, which helps regulate blood sugar levels. Among other diabetes peptides, we provide the peptide (CAS: 910463-68-2) for research purposes only! 𝗖𝗵𝗲𝗰𝗸 𝗼𝘂𝘁 𝗼𝘂𝗿 𝗰𝗮𝘁𝗮𝗹𝗼𝗴! Check the comments for the link 👇 #myjpt #ozempic #rybelsus #glp1 #semaglutide #diabetesresearch #diabetes #obesity
-
-
...They do look a bit different, don't they?... 👀 ‼️ 𝗨𝗣𝗗𝗔𝗧𝗘 𝗨𝗣𝗗𝗔𝗧𝗘 𝗨𝗣𝗗𝗔𝗧𝗘 ‼️ Big news from the JPT team: With our move to a new address we are officially updating our logo and corporate design! 𝗪𝗲 𝗠𝗮𝗸𝗲 𝗣𝗲𝗽𝘁𝗶𝗱𝗲𝘀! As pioneers in the peptide space, peptides are at the core of everything we do, and our visual identity reflects that. This new look is more than just an aesthetic change: it is a fresh step forward as we continue to grow, collaborate, and push boundaries in peptide science, while remaining your trusted and reliable source for quality peptides. 🚀 Sleek, modern, and science-forward - just like us. A huge shoutout to our amazing team and the graphic designers who helped bring this vision to life: Cristina Boboc The upcoming weeks you will notice the continious changes to our look. What do you think?! #myjpt #newlogo #corporateidentity #corporatedesign #tagline
-
𝗦𝗼 𝗺𝘂𝗰𝗵 𝘁𝗼 𝗽𝗮𝗰𝗸! 🏢 Did you ever see large laboratory equipment being floated through the air for transport? How complex the move is when it comes to laboratories in general? Here are some impressions from this and last week's move. Here is to JPT's new era! 🥂 #myjpt #newlogo #newbuilding Special thanks to DMS LOGISTICS
-
-
It looks chaotic, but the move to the new 𝗛𝗼𝘂𝘀𝗲 𝗼𝗳 𝗣𝗲𝗽𝘁𝗶𝗱𝗲𝘀 (𝗛𝗼𝗣) is almost complete! Moving laboratory equipment is quite the challenge when one wants to maintain continous and a high-quality peptide production. It requires specialized handling, a minutious moving-schedule, and a combined effort of many people to make it happen. A special thank you to DMS LOGISTICS! #myjpt #newbuidling #HoP
✨ Exciting times at JPT Peptide Technologies ! ✨ A new chapter begins as we move into our brand-new peptide manufacturing plant, the result of 4 years of construction and dedication. It has been a long and challenging journey for JPT and our partners (not to say very difficult 😆), but the outcome is worth it: 🏭 8,500 m² / 92,000 ft² of state-of-the-art facilities ⚙️ Expanded production capacities and automation 👷 Improved working and safety conditions 🌱 Enhanced energy efficiency A big thank you to all our colleagues for their tremendous efforts and for preparing this move so smoothly and limiting downtime. Gut gemacht 💪 👉 Stay tuned — more information and pictures are coming soon!
-
-
We're #hiring a new HR Business Partner (m/w/d) in Berlin, Berlin. Apply today or share this post with your network.
-
𝗪𝗵𝗼 𝗶𝘀 𝘀𝗵𝗲? 👀 Have you met the newest addition to the JPT European Business Development team? You may have caught a glimpse of her in recent weeks. 𝗣𝗹𝗲𝗮𝘀𝗲 𝗷𝗼𝗶𝗻 𝘂𝘀 𝗶𝗻 𝘄𝗲𝗹𝗰𝗼𝗺𝗶𝗻𝗴 Zohreh Bandegani 𝘁𝗼 𝗝𝗣𝗧! -Based in London, UK, Zohreh will offer a valuable English perspective and help to expand JPT's reach in Europe. ⁉️ -With a background in cancer pharmacology, she is here to provide expertise and answer your questions. 👩🔬 -Sociable, Knowledgable, Experienced 💬 So come and reach out! #myjpt #businessdevelopment #sales #pepmix #peptide #pharmacology
-
-
🥨 𝗦𝗼𝗺𝗲 𝗿𝗮𝘁𝗵𝗲𝗿 𝗰𝗵𝗮𝗼𝘁𝗶𝗰 𝗯𝘂𝘁 𝗳𝘂𝗻 𝗶𝗺𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻𝘀 𝗳𝗿𝗼𝗺 𝗹𝗮𝘀𝘁 𝘄𝗲𝗲𝗸'𝘀 𝗜𝗨𝗜𝗦. 🌭 -Our Managing director Aurélien Claeyssen got inspired by our mascot in goggles, and dressed for the occasion -Besides talking to clients, Michael Drosch became the ultimate builder and set-designer -Our newest addition to the business development team in Europe, Zohreh Bandegani launched herself into the crowds, familiarizing herself with the peptide family -Brass bands, Wiener Schnitzel and other great localities 🥨 Waltzing into the Future of Immunology: For a better Health 𝗪𝗵𝗼 𝗱𝗶𝗱 𝘆𝗼𝘂 𝗺𝗲𝗲𝘁 𝗮𝘁 𝘁𝗵𝗲 𝗜𝗨𝗜𝗦? #iuis2025 #myjpt #conference #immunology
-
-
-
-
-
+2
-